Syntekabio Launches Global Marketing Campaign Featuring 'Pre-Development Post-Payment' Model
Syntekabio is driving its global market expansion with a service model based on a develop-first, pay-later approach.
AI drug development specialist Syntekabio (CEO Jeong Jong-seon) announced on the 11th that it will aggressively launch a global marketing campaign for its ‘DP (Develop Now, Pay Later) Program’ ahead of the upcoming ‘BioTechX USA’ event on the 17th.
Syntekabio’s DP Program is a service model that offers its AI drug platform ‘DeepMatcher’ on a develop-first, pay-later basis. This program features proactive AI screening for the target desired by the client company to secure active compounds first, allowing the client to decide whether to proceed with the service afterward.
Clients can choose to make payment and continue with additional steps after reviewing the results. This significantly reduces the risk for clients depending on whether results are produced, drawing considerable attention.
For the global marketing campaign of the DP Program, Syntekabio is collaborating with a global bio-specialized communication agency to conduct various marketing activities including surveys, advertising, social media, and press relations.
The company will participate as the title sponsor at ‘BioTechX USA 2024,’ held from the 17th to 18th (local time) in Pennsylvania, USA, to extensively promote the DP Program. BioTechX USA is Europe’s largest conference on digital innovation in diagnostics, drug development, and healthcare, covering diverse agendas such as bio data, genomics, AI drug development, and chemoinformatics.
Jeong Jong-seon, CEO of Syntekabio, stated, “The DP Program is a customer-friendly service model designed for potential clients interested in our AI drug platform services but concerned about cost expenditure and risks related to outcome generation.” He added, “The main goal of this marketing campaign is to emphasize Syntekabio’s technological confidence and to generate client interest in the DP Program.”
Hot Picks Today
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- [Breaking] Park Sukeun, Central Labor Relations Commission Chair: "Some Gaps Narrowed Between Samsung Electronics Labor and Management"
- Is This the Peak? As Others Hesitate..."The Answer Is Clear for Surviving the KOSPI 10,000 Era"
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
He also noted, “We have already received inquiries about the DP Program and are engaged in positive discussions with multiple partners, and we will strive to advance these into formal contracts.”
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.